Lechner MG - Search Results

1

Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphoma.

Lechner MG, Megiel C, Church CH, Angell TE, Russell SM, Sevell RB, Jang JK, Brody GS, Epstein AL. Lechner MG, et al. Clin Cancer Res. 2012 Sep 1;18(17):4549-59. doi: 10.1158/1078-0432.CCR-12-0101. Epub 2012 Jul 12. Clin Cancer Res. 2012. PMID: 22791880

2

Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1.

Liebertz DJ, Lechner MG, Masood R, Sinha UK, Han J, Puri RK, Correa AJ, Epstein AL. Liebertz DJ, et al. Among authors: lechner mg. Head Neck Oncol. 2010 Feb 22;2:5. doi: 10.1186/1758-3284-2-5. Head Neck Oncol. 2010. PMID: 20175927 Free PMC article.

3

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.

Lechner MG, Liebertz DJ, Epstein AL. Lechner MG, et al. J Immunol. 2010 Aug 15;185(4):2273-84. doi: 10.4049/jimmunol.1000901. Epub 2010 Jul 19. J Immunol. 2010. PMID: 20644162 Free PMC article.

4

A new mechanism for blocking myeloid-derived suppressor cells by CpG.

Lechner MG, Epstein AL. Lechner MG, et al. Clin Cancer Res. 2011 Apr 1;17(7):1645-8. doi: 10.1158/1078-0432.CCR-11-0024. Epub 2011 Feb 2. Clin Cancer Res. 2011. PMID: 21288925 Free PMC article.

5

Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity.

Lechner MG, Lade S, Liebertz DJ, Prince HM, Brody GS, Webster HR, Epstein AL. Lechner MG, et al. Cancer. 2011 Apr 1;117(7):1478-89. doi: 10.1002/cncr.25654. Epub 2010 Nov 8. Cancer. 2011. PMID: 21425149 Free PMC article.

6

Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.

Lechner MG, Megiel C, Russell SM, Bingham B, Arger N, Woo T, Epstein AL. Lechner MG, et al. J Transl Med. 2011 Jun 9;9:90. doi: 10.1186/1479-5876-9-90. J Transl Med. 2011. PMID: 21658270 Free PMC article.

7

USC-HN2, a new model cell line for recurrent oral cavity squamous cell carcinoma with immunosuppressive characteristics.

Russell SM, Lechner MG, Gong L, Megiel C, Liebertz DJ, Masood R, Correa AJ, Han J, Puri RK, Sinha UK, Epstein AL. Russell SM, et al. Among authors: lechner mg. Oral Oncol. 2011 Sep;47(9):810-7. doi: 10.1016/j.oraloncology.2011.05.015. Epub 2011 Jun 29. Oral Oncol. 2011. PMID: 21719345 Free PMC article.

8

Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors.

Lechner MG, Russell SM, Bass RS, Epstein AL. Lechner MG, et al. Immunotherapy. 2011 Nov;3(11):1317-40. doi: 10.2217/imt.11.115. Immunotherapy. 2011. PMID: 22053884 Free PMC article. Review.

9

An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas.

Murphy KA, Lechner MG, Popescu FE, Bedi J, Decker SA, Hu P, Erickson JR, O'Sullivan MG, Swier L, Salazar AM, Olin MR, Epstein AL, Ohlfest JR. Murphy KA, et al. Among authors: lechner mg. Clin Cancer Res. 2012 Sep 1;18(17):4657-68. doi: 10.1158/1078-0432.CCR-12-0990. Epub 2012 Jul 10. Clin Cancer Res. 2012. PMID: 22781551 Free PMC article.

10

Generation of tumor-targeted antibody-CpG conjugates.

Li Z, Jang JK, Lechner MG, Hu P, Khawli L, Scannell CA, Epstein AL. Li Z, et al. Among authors: lechner mg. J Immunol Methods. 2013 Mar 29;389(1-2):45-51. doi: 10.1016/j.jim.2012.12.009. Epub 2012 Dec 29. J Immunol Methods. 2013. PMID: 23279945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters